Reduction/elimination of blood eosinophils in severe asthma: should there be a safety consideration?
Author:
Affiliation:
1. Respiratory Department, 424 Army General Hospital, Thessaloniki, Greece
2. 2nd Respiratory Department, Attiko University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece
Funder
not funded
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1960977
Reference82 articles.
1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
2. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
3. Different endotypes and phenotypes drive the heterogeneity in severe asthma
4. Biological treatments for severe asthma: A major advance in asthma care
5. Eosinophils in health and disease: the LIAR hypothesis
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rhizoma Dioscoreae Nipponicae Relieves Asthma by Inducing the Ferroptosis of Eosinophils and Inhibiting the p38 MAPK Signaling Pathway;Critical Reviews in Immunology;2024
2. A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021;Frontiers in Pharmacology;2022-10-03
3. Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma;Biomedicines;2022-09-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3